VERA

Vera Therapeutics
VERA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.45B
EV
$914.86M
Shares Outstanding
65.19M
Beta
1.13

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$64.00
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Vera Therapeutics, Inc.

gainify
VERA

Vera Therapeutics, Inc.

VERA

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous inject...

Sector

Healthcare

Industry

Biotechnology

CEO

Fordyce, Marshall

Employees

152

Website

veratx.com

IPO Date

2021-05-14

Headquarters

8000 Marina Boulevard, Suite 120, Brisbane, California, 94005, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.